Initializing Vogelview...
Performing medical cross-referencing...
Initializing Vogelview...
Performing medical cross-referencing...
Loading...
Normal Lp-PLA2 below 200 ng/mL places you in the lower cardiovascular risk category for this marker. While not in the optimal low zone, this level does not indicate high vascular inflammation from this enzyme. Lp-PLA2 is best used as one component of comprehensive cardiovascular risk assessment.
Lipoprotein-associated phospholipase A2 is an inflammatory enzyme that travels with LDL particles inside arterial plaques. It generates pro-inflammatory and cytotoxic products that contribute to plaque instability and rupture. Very low levels mean minimal plaque-destabilizing enzymatic activity, which is highly favorable for cardiovascular health.
Excellent result. Very low Lp-PLA2 is a strong cardiovascular protection marker.
Lp-PLA2: {{value}} {{unit}} — very low (ref: <{{high}})Low Lp-PLA2 indicates minimal activity of this plaque-destabilizing enzyme. When this enzyme is less active, arterial plaques are more stable and less likely to rupture and cause acute heart attacks or strokes. Low Lp-PLA2 is associated with noticeably lower cardiovascular event risk.
Good cardiovascular risk indicator. Low Lp-PLA2 supports stable, less inflammatory arterial plaques.
Lp-PLA2: {{value}} {{unit}} — low (ref: <{{high}})A borderline low Lp-PLA2 is within the favorable low range. Plaque-destabilizing enzyme activity is minimal, which supports arterial plaque stability. This is a positive cardiovascular marker that adds complementary information to LDL and CRP measurements.
Good result. Continue anti-inflammatory and lipid-healthy lifestyle choices.
Lp-PLA2: {{value}} {{unit}} — low normal (ref: <{{high}})Normal Lp-PLA2 below 200 ng/mL places you in the lower cardiovascular risk category for this marker. While not in the optimal low zone, this level does not indicate high vascular inflammation from this enzyme. Lp-PLA2 is best used as one component of comprehensive cardiovascular risk assessment.
Normal result. Combine with lipid panel, hs-CRP (a blood marker of low-grade inflammation), and other cardiac markers for comprehensive risk assessment.
Lp-PLA2: {{value}} {{unit}} — normal (ref: <{{high}})An optimal Lp-PLA2 below 150 ng/mL reflects low levels of this vascular inflammatory enzyme, associated with more stable arterial plaques and lower cardiovascular event risk. Combined with low ApoB (the protein that carries bad cholesterol particles) and low hs-CRP (a blood marker of low-grade inflammation), optimal Lp-PLA2 paints a reassuring cardiovascular risk picture.
Excellent cardiovascular marker. Continue lipid-healthy, anti-inflammatory lifestyle habits.
Lp-PLA2: {{value}} {{unit}} — optimal (ref: <150)A borderline elevated Lp-PLA2 means this vascular inflammatory enzyme is at levels where it begins to contribute to plaque vulnerability. The enzyme generates lyso-phosphatidylcholine and oxidized fatty acids inside plaques, which attract macrophages, thin the fibrous cap, and make plaques more likely to rupture. Borderline elevation warrants addressing all modifiable cardiovascular risk factors.
Discuss with your doctor. Statin therapy in particular lowers Lp-PLA2. Address LDL, blood pressure, and lifestyle risk factors concurrently.
Lp-PLA2: {{value}} {{unit}} — borderline elevated (ref: <{{high}}; borderline: 200–235)Elevated Lp-PLA2 above 235 ng/mL is associated with a noticeably increased risk of cardiovascular events, particularly stroke and coronary artery disease. High Lp-PLA2 activity inside arterial plaques generates toxic products that destabilize plaques, making them more prone to rupture and trigger acute heart attacks or strokes. This marker is particularly informative for individuals with apparently normal LDL cholesterol.
Discuss urgently with your cardiologist. Statin therapy specifically lowers Lp-PLA2. Aggressive cardiovascular risk factor management is needed alongside consideration of Lp-PLA2-targeted therapy.
Lp-PLA2: {{value}} {{unit}} — elevated — high vascular inflammation risk (ref: <{{high}}; elevated: >235)Very high Lp-PLA2 above 400 ng/mL represents very high vascular inflammatory enzyme activity, indicating highly unstable arterial plaques at serious risk of rupture. This level noticeably elevates the risk of acute coronary syndrome and ischemic stroke, particularly when combined with other cardiovascular risk markers. This pattern may indicate advanced or accelerated atherosclerotic disease.
Urgent cardiovascular evaluation is needed. This level warrants comprehensive cardiac imaging and aggressive multi-modal cardiovascular risk reduction therapy.
Lp-PLA2: {{value}} {{unit}} — very high (ref: <{{high}}; critical: >400)Upload your lab report and get your actual values interpreted in plain English — instantly, with no medical training required.